Literature DB >> 32071132

Current Bronchodilator Responsiveness Criteria Underestimate Asthma in Older Adults.

Rodrigo S Cavallazzi1, Barbara J Polivka2, Bryan L Beatty1, Demetra E Antimisiaris3, Rangaraj K Gopalraj4, Rachel A Vickers-Smith5, Rodney J Folz6.   

Abstract

BACKGROUND: Asthma is common in older adults and is confirmed by demonstration of variable expiratory air-flow limitations, typically evaluated by spirometric assessment of bronchodilator responsiveness. However, many patients with clinically suspected asthma and documented air-flow obstruction do not exhibit a post-bronchodilator response that meets or exceeds current established guidelines. We investigated if extending the time from bronchodilator administration to assessment of bronchodilator response increases the yield of spirometry for the diagnosis of asthma in older adults.
METHODS: This was a cross-sectional study. The subjects were non-smokers, ≥ 60 y old, and with suspected asthma. Subjects were characterized as (1) those with a positive bronchodilator response on the 30-min post-bronchodilator spirometry, (2) those with a positive bronchodilator response on the 60-min post-bronchodilator spirometry, and (3) those without a positive bronchodilator response but with a positive methacholine challenge test. Factors associated with a late response to bronchodilator were evaluated by using bivariate analysis and by multivariate analysis by using a logistic regression model.
RESULTS: This study enrolled 165 subjects. Of these, 81 (49.1%) had a positive bronchodilator response on 30-min post-bronchodilator spirometry; 25 (15.2%) had a positive bronchodilator response on the 1-h post-bronchodilator spirometry; and 59 (35.8%) had no positive bronchodilator response but had a positive methacholine challenge test. On multivariable regression analysis, those with a higher baseline percentage of predicted FEV1, higher scores on a standard asthma control test, and wheezing and/or cough after exercise were more likely to either have a late bronchodilator response or no bronchodilator response.
CONCLUSIONS: Our study showed that a late positive response to bronchodilator use was more common than previously presumed in older subjects with suspected asthma. Pulmonary function testing laboratories should consider routinely reassessing spirometry at 1 h after bronchodilator use if the earlier assessment did not reveal a significant response.
Copyright © 2020 by Daedalus Enterprises.

Entities:  

Keywords:  aging; albuterol; asthma; bronchodilator effect; lung diseases; older adult; spirometry

Mesh:

Substances:

Year:  2020        PMID: 32071132      PMCID: PMC7538007          DOI: 10.4187/respcare.07132

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  40 in total

1.  Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.

Authors:  D Fishwick; L Bradshaw; C Macdonald; R Beasley; D Gash; T Bengtsson; E Bondesson; L Borgström
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

Review 2.  Interactions between corticosteroids and beta2-agonists.

Authors:  Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

3.  Mechanism of isoproterenol-induced desensitization of tracheal smooth muscle.

Authors:  C S Lin; L Hurwitz; J Jenne; B P Avner
Journal:  J Pharmacol Exp Ther       Date:  1977-10       Impact factor: 4.030

4.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.

Authors:  E Israel; J M Drazen; S B Liggett; H A Boushey; R M Cherniack; V M Chinchilli; D M Cooper; J V Fahy; J E Fish; J G Ford; M Kraft; S Kunselman; S C Lazarus; R F Lemanske; R J Martin; D E McLean; S P Peters; E K Silverman; C A Sorkness; S J Szefler; S T Weiss; C N Yandava
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

5.  Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.

Authors:  Mario Castro; Jonathan Corren; Ian D Pavord; Jorge Maspero; Sally Wenzel; Klaus F Rabe; William W Busse; Linda Ford; Lawrence Sher; J Mark FitzGerald; Constance Katelaris; Yuji Tohda; Bingzhi Zhang; Heribert Staudinger; Gianluca Pirozzi; Nikhil Amin; Marcella Ruddy; Bolanle Akinlade; Asif Khan; Jingdong Chao; Renata Martincova; Neil M H Graham; Jennifer D Hamilton; Brian N Swanson; Neil Stahl; George D Yancopoulos; Ariel Teper
Journal:  N Engl J Med       Date:  2018-05-21       Impact factor: 91.245

6.  Predicting asthma in older adults on the basis of clinical history.

Authors:  Rodrigo Cavallazzi; Anna Jorayeva; Bryan L Beatty; Demetra Antimisiaris; Rangaraj Gopalraj; John Myers; Rodney J Folz; Barbara J Polivka
Journal:  Respir Med       Date:  2018-07-20       Impact factor: 3.415

Review 7.  Allergy and asthma in the elderly.

Authors:  Sameer K Mathur
Journal:  Semin Respir Crit Care Med       Date:  2010-10-12       Impact factor: 3.119

8.  Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: response to albuterol, isoproterenol, and placebo aerosols.

Authors:  S L Spector; M Garza Gomez
Journal:  J Allergy Clin Immunol       Date:  1977-04       Impact factor: 10.793

9.  Age-related changes in beta-adrenergic neuroeffector systems in the human heart.

Authors:  M White; R Roden; W Minobe; M F Khan; P Larrabee; M Wollmering; J D Port; F Anderson; D Campbell; A M Feldman
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

Review 10.  The long and short of beta2-agonists.

Authors:  J Lötvall
Journal:  Pulm Pharmacol Ther       Date:  2002       Impact factor: 3.410

View more
  1 in total

1.  Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review.

Authors:  Mohammed A Almeshari; Nowaf Y Alobaidi; Elizabeth Sapey; Omar Usmani; Robert A Stockley; James A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.